In a large cohort of patients with juvenile idiopathic arthritis it was found that increased levels of S100A12 and calprotectin, in addition to high-sensitivity C-reactive protein, indicated subclinical inflammation and thereby could identify patients with increased risk of relapse when in clinical remission [19]. Here, S100A12 is linked to juvenile idiopathic arthritis.